Periscope Capital’s Longevity Health Holdings, Inc. Common Stock XAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-38,789
Closed -$12M 630
2023
Q2
$12M Buy
38,789
+17,090
+79% +$5.24M 0.93% 21
2023
Q1
$6.61M Buy
21,699
+9,228
+74% +$2.78M 0.31% 123
2022
Q4
$3.71M Sell
12,471
-4,166
-25% -$1.23M 0.16% 249
2022
Q3
$4.85M Hold
16,637
0.14% 294
2022
Q2
$4.83M Hold
16,637
0.13% 330
2022
Q1
$4.86M Buy
+16,637
New +$4.82M 0.13% 336

Other funds holding XAGE

Periscope Capital's XAGE Position: Q3 2023 in Review

Periscope Capital sold out of Longevity Health Holdings, Inc. Common Stock (XAGE) in Q3 2023, closing a stake of 38,789 shares — an estimated $12M sold.

Periscope Capital first reported a position in XAGE in Q1 2022 and held it in 6 quarters. The position peaked at $12M in Q2 2023. 14 funds tracked by Wall St. Rank hold XAGE as of Q3 2023.

  • Periscope Capital reported no remaining Longevity Health Holdings, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Periscope Capital sold 38,789 Longevity Health Holdings, Inc. Common Stock shares in Q3 2023, an estimated $12M.
  • Periscope Capital first reported a position in Longevity Health Holdings, Inc. Common Stock in Q1 2022 and held it in 6 quarters.
  • Periscope Capital's Longevity Health Holdings, Inc. Common Stock position peaked at $12M in Q2 2023.
  • 14 funds tracked by Wall St. Rank held Longevity Health Holdings, Inc. Common Stock as of Q3 2023.

Based on Periscope Capital's 13F filing for Q3 2023, filed 6 Nov 2023.